… thyroid cancer (thought to arise from the differentiated thyroid cancers) or primary thyroid …
Within the differentiated thyroid cancer family, papillary thyroid cancer accounts for more …

… thyroid cancer (MTC) and focuses on the current use of molecular, biochemical, and imaging
disease markers as a basis for selection of appropriate therapy… differentiated thyroid cancer …

… and will be termed thyroid cancer for the purposes of this review. Thyroid cancer incidence
has … Thus, high-risk small nodules that are not sampled also should be monitored in a manner …

… TSH in patients with low-risk thyroid cancer. Moreover, TSH suppression implies … thyroid
cancer require long-term TSH-suppressive doses of L-T 4 . In these patients, careful monitoring …

… Based on the GLOBOCAN 2020 database of cancer incidence and mortality by the WHO
International Agency for Research on Cancer, thyroid cancer has the ninth highest cancer …

… In conclusion, in thyroid cancer as well as in other tumours, 18F-FDG PET is a sensitive
method for monitoring of response to new therapies like 13-cis-RA. It can predict the …

… while appropriately treating and monitoring patients who are at higher risk. These changes
and the need for new risk-stratified approaches for patients with thyroid cancer have recently …

… We must stress, however, that the risk of thyroid cancer recurrence for any … Risk of thyroid
cancer recurrence … , further monitoring of stimulated thyroglobulin offers no benefit 73,74,75 . …

… to diagnose and monitor patients with goiter, thyroid nodules, or thyroid cancer requires an
appreciation of the pathophysiologic factors implicated in thyroid hyperplasia and neoplasia: …

… of thyroid cancer. This paper will not discuss off-label use of combination TKI therapy …
not been well established in thyroid cancer patients and are beyond the scope of this paper. …